Fluoxetine treatment of anger attacks: a replication study

Area of Science:

• Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Anger attacks, characterized by intense autonomic arousal and situational inappropriateness, are a notable symptom in major depressive disorder.
• Assessing the prevalence and treatment of anger attacks is crucial for improving patient outcomes in depression.

Purpose of the Study:

• To investigate the efficacy of fluoxetine in reducing anger attacks among patients diagnosed with major depression.
• To determine the prevalence of anger attacks before and after an 8-week open-label fluoxetine treatment course.

Main Methods:

• 164 patients with major depression were assessed for anger attacks using the Anger Attacks Questionnaire.
• Patients received open-label fluoxetine (20 mg/day) for 8 weeks.
• Pre- and post-treatment assessments of anger attacks were conducted.

Main Results:

• At baseline, 39% of patients reported experiencing anger attacks.
• Following 8 weeks of fluoxetine treatment, 64% of patients who initially had anger attacks no longer reported them.
• A statistically significant reduction in anger attacks was observed post-treatment (chi 2 = 22.7, p < .0005).

Conclusions:

• Fluoxetine treatment demonstrates significant efficacy in alleviating anger attacks in patients with major depression.
• The findings suggest that fluoxetine is a viable therapeutic option for managing anger attacks associated with depression.